Korean Cancer Study Group 
Webzine Vol.24  JUNE 2022 
논문 발간현황 2022.01 - 2022.05

▶ BR16-09 | PMID : 35344650

Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09) 

Cancer Res Treat. 2022 Mar 24.

DOI: 10.4143/crt.2021.1561. 


▶ LU20-11 | PMID : 34705268

Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11) 

Cancer. 2022 Feb 15;128(4):778-787.

DOI: 10.1002/cncr.33984. 



▶ HN13-01 | PMID : 34929077

Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)

Korean J Intern Med. 2022 Jan;37(1):190-200.

DOI: 10.3904/kjim.2020.636.



▶ ST19-16 | PMID : 35015188

Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16) 

Gastric Cancer. 2022 May;25(3):609-618.

DOI: 10.1007/s10120-021-01276-4.



▶ KPMNG 정밀의료 진료지침 | PMID : 34902959

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group

Cancer Res Treat. 2022 Jan;54(1):1-9.

DOI: 10.4143/crt.2021.1115.